Skip to main content

Leonardo DRS to Acquire Raft, Expanding Multi-Domain AI, Data Fusion and Mission Software Capabilities

Acquisition adds new capabilities in open-architecture software and AI to support integrated mission solutions ARLINGTON, Va., July 28, 2026 (GLOBE NEWSWIRE) — Leonardo DRS, Inc. (Nasdaq: DRS) today announced that it has entered into a definitive agreement to acquire Raft LLC (“Raft”) in an all-cash transaction valued at $450 million. Founded in 2018 and headquartered in McLean, Virginia, Raft provides open-architecture mission software, specializing in multi-domain data fusion and artificial intelligence (AI) that supports real-time situational awareness and faster operational decision-making for national security customers. The acquisition is aligned with DRS’s strategy and enhances its ability to deliver integrated, mission-focused technologies that help customers operate with greater speed, clarity and confidence in complex...

Continue reading

SMJ International Holdings Inc. Announces Filing of Its Form 20-F for Fiscal Year 2026

SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) — SMJ International Holdings Inc. (NYSE American: SMJF) (“SMJ” or the “Company”), a Singapore-based premium flooring specialist that distributes a wide range of premium flooring products under its proprietary “SMJ” brand across Asia markets, today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2026 with the Securities and Exchange Commission (the “SEC”). SMJ’s Annual Report on Form 20-F can be accessed by visiting either the SEC’s website at www.sec.gov or the “SEC Filings” section of the Company’s Investor Relations website at https://investors.smjf.com.sg/. In addition, the Company will provide a hard copy of the Annual Report containing audited consolidated financial statements, free of charge, to its shareholders upon request. Requests...

Continue reading

Eurobio Scientific: First half of 2026, Continuation of the strategic transformation

FIRST HALF OF 2026, CONTINUATION OF THE STRATEGIC TRANSFORMATIONFirst-half revenue up 5% to €84.5 million Continuation of the Group’s strategy:Proprietary products: 37% of revenue International expansion: 47% of revenue generated outside FranceParis, July 28, 2026 – 5:45 pm Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medical diagnostics and life sciences, today reports its half-year revenue as of June 30, 2026. 5% revenue growthAs of June 30, 2026, Eurobio Scientific reported revenue of €84.5 million, compared to €80.7 million as of June 30, 2025, representing an increase of approximately 5%. On a comparable pro forma basis—that is, excluding the impact of changes in scope resulting from acquisitions—revenue remained stable. The impact of changes in scope primarily relates to the integration of...

Continue reading

GTT – First half 2026 results – Orderbook on high historical levels

First half 2026 results:Orderbook on high historical levels;Strong results;Annual objectives confirmedStrong business activity: 65 orders recorded in the first half of 2026 Revenue: 387.3 million euros, stable compared with the first half of 2025 EBITDA: 263.6 million euros, with an EBITDA margin of 68.1% Interim dividend: 4.30 euros per shareParis, July 28, 2026. GTT, the technological expert in membrane containment systems used to transport and store liquefied gases, today announces its results for the first half of 2026. Commenting on the results, François Michel, Chief Executive Officer of GTT, said: “The 65 orders recorded in the first half of 2026 confirm GTT’s strong commercial performance over the period. Geopolitical disruptions have had no impact on demand for new LNG carriers. The signing of additional investment decisions...

Continue reading

SMCP – 2026 H1 Results

2026 H1 ResultsPress release – Paris, July 28th, 2026  Sales growth supported by America and the EMEA regionStrong improvement in profitability, enhanced financial discipline and full-year guidance confirmed 2026 H1 Sales at €597m, increasing by +0.6% on an organic1 basis compared with 2025 H1 Sales (€601m)Solid organic sales growth during the semester in America and in the EMEA region; organic growth confirmed in Asia Pacific; decline in France, impacted by a weak consumption environment and the contraction of the network Sales trend improvement in Q2, revenue amounts to €310m, +2.0% organic compared with Q2 2025 Sales (€305m), vs -0.8% in Q1 Good like-for-like sales growth in Q2 (+3.9%), contributing to positive growth for the first half as a whole (+1.6%) Very dynamic performance from Maje (+5.2% organic growth) across all regions,...

Continue reading

Kering – 2026 First-half results: back to growth, performance improvement & strategy execution on track

 Kering – H1 26 – Press Release – 28 07 26PRESS RELEASEJuly 28, 2026        2026 FIRST-HALF RESULTS: BACK TO GROWTH,PERFORMANCE IMPROVEMENT &STRATEGY EXECUTION ON TRACK First-half revenue at €7,220 million, +1% on a comparable basisSequential improvement with Q2 revenue at €3,652 million, +2% on a comparable basis with a marked acceleration at Gucci, in retail: +7pts Enhanced operating performance with recurring operating margin at 12.8% of revenue; €921 million All key execution levers on track or ahead of plan Net debt: €3.3 billion reduced by €4.7 billion since December 31, 2025 “Kering delivered improved performance in the second quarter, with revenue returning to growth. Across the Group, we are seeing early signs of progress in brand desirability, commercial momentum and operating performance. The...

Continue reading

Edible Garden Receives Favorable Decision from Nasdaq Hearings Panel

Company Advances Farm-to-Formula® Strategy and Webster City Ready-to-Drink Manufacturing Buildout BELVIDERE, NJ, July 28, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform, today announced that the Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market, subject to the condition that the Company demonstrate compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of at least $1.00 per share, on or before August 15, 2026. As previously announced, the Company effected a 1-for-45 reverse stock split of its common stock,...

Continue reading

Lincoln Tech Campus Among USA Today’s “Top Vocational Schools” for 2026

Melrose Park, IL school recognized for commitment to student success, diversity.Lincoln Tech Is a National Leader in Hands-On Career TrainingStudents gain practical experience using the tools and technology aligned with industry expectations.Lincoln Tech Focuses on Student SuccessStudents benefit from training programs designed to help them develop skills valued by today’s employers.Parsippany, N.J., July 28, 2026 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for 80 years, announced today that its Melrose Park, IL campus has been named one of “America’s Top Vocational Schools” for 2026 by USA Today. The campus selection was based on a number of factors focused on student success and commitment to diversity. The campus was...

Continue reading

Rio2 Announces Participation in Royal Road’s Brokered Life Offering

VANCOUVER, British Columbia, July 28, 2026 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2”) (TSX: RIO; OTCQX: RIOFF; BVL: RIO) announces that it has participated in the Royal Road Minerals Limited (“Royal Road”) Brokered LIFE Offering which closed on July 28, 2026 with the purchase of 10,000,000 ordinary shares of Royal Road at the price of $0.20 per share ($2,000,000 in total). Pursuant to the Investor Rights Agreement announced on September 29, 2025, Rio2 has the right to participate in equity financings by Royal Road to maintain its pro rata ownership in Royal Road at the time of any such financing or acquire up to a 15% ownership interest in Royal Road (after giving effect to the financing) provided that Rio2 owns at least a 9.5% in Royal Road (calculated in accordance with the Investor Rights Agreement). Following the completion of...

Continue reading

Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

Transformative funding agreement equips Instinct Bio with discretionary capital to scale its longevity-focused ecosystem and capture market opportunities. New York, NY, July 28, 2026 (GLOBE NEWSWIRE) — INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) (“Instinct Bio” or the “Company”) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period. Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from time to time, subject to specified limitations, conditions and regulatory requirements. The purchase...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.